Narcolepsy Therapeutics Market By Type ( Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy ), By Drug ( Central Nervous System Stimulants, Sodium Oxybate, Norepinephrine reuptake inhibitor (NRI), Tricyclic Antidepressants ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 188

 ERC 4926


Narcolepsy Therapeutics Market is expected to grow with a CAGR of 6.1% during the forecast period of 2018 to 2025.

Narcolepsy is neurological disorder that disrupts the sleep-wake cycle in humans, leading to excessive daytime sleepiness and loss of muscle strength. It is a long-term disorder that affects men and women equally and often commences from the childhood itself. Narcolepsy can be controlled with the help of certain therapeutic drugs, but no permanent cure has been discovered until now. Narcolepsy treatment is mainly carried out by the oral administration of the drugs; however, a change in the lifestyle of the patient has also proved to be effective in treating the disorder. The global narcolepsy therapeutics market is experiencing hurdles in its growth due to the symptomatic treatments used for treating the neurodegenerative disorder and the potential side effects of the therapeutics drugs administered by the patients. However, the increasing awareness among the global populace regarding narcolepsy and the advancements taking place in the healthcare industry are expected to fuel the growth of narcolepsy therapeutics market. In terms of region, North America is anticipated to lead the market, owing to the high prevalence of the disorder in the region. According to the data revealed by Narcolepsy Network, 1 in every 2000 people in the U.S. are affected by narcolepsy, i.e. 200,000 Americans. As per a certain research study, only 25% of the people affected with narcolepsy are diagnosed and treated, whereas, the rest 75% are left undiagnosed or misdiagnosed. Such notable percentage figure is anticipated to provide lucrative opportunities to the market players during the upcoming years, in correlation to the technological advancements occurring in the medical diagnosis.

The report provides detailed qualitative and quantitative analysis of the narcolepsy therapeutics market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely type and drug in each of the major regions.

Narcolepsy Therapeutics Market Player Analysis -

The report presents detailed analysis of major players operating in narcolepsy therapeutics market. Few of the include Jazz Pharmaceuticals PLC, Teva Pharmaceutical Industries Ltd., Shire, Ligand Pharmaceuticals Inc., Graymark Healthcare Inc., Addrenex Pharmaceuticals Inc., and BIOPROJET. Detailed coverage on these market players with information on their revenue from narcolepsy therapeutics business, market share, and their growth strategies have been provided in the report.

Narcolepsy Therapeutics Market Segmentation

The global narcolepsy therapeutics market is segmented on the basis of type, drug and geography. By type, the market is segmented into Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy. On the basis of drug, the market is categorized into Central Nervous System Stimulants, Sodium Oxybate, Norepinephrine reuptake inhibitor (NRI), Tricyclic Antidepressants, and Others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Narcolepsy Therapeutics Market Segmentation

By Type
    • Narcolepsy with Cataplexy
    • Narcolepsy without Cataplexy
    • Secondary Narcolepsy

By Drug
    • Central Nervous System Stimulants
    • Sodium Oxybate
    • Norepinephrine reuptake inhibitor (NRI)
    • Tricyclic Antidepressants
    • Others

By Geography
    • North America
              o U.S.
              o Canada
              o Mexico
    • Europe
              o U.K.
              o France
              o Germany
              o Italy
              o Spain
              o Rest of Europe
    • Asia-Pacific
              o China
              o Japan
              o India
              o Korea
              o Rest of APAC
    • South America
              o Brazil
              o Rest of South America
    • Rest of the World
              o Middle East
              o Africa

Narcolepsy Therapeutics Market Key Players

• Jazz Pharmaceuticals PLC
• Teva Pharmaceutical Industries Ltd.
• Shire
• Ligand Pharmaceuticals Inc.
• Graymark Healthcare Inc.
• Addrenex Pharmaceuticals Inc.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Narcolepsy Therapeutics Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Narcolepsy Therapeutics Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!